Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH17-140K24.8 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | FAM117A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
mRNA | PRRX2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
mRNA | RBL2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
mRNA | IL13RA2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | CRB3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
mRNA | C2orf54 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | ST6GALNAC2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
mRNA | SMIM13 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
mRNA | RBM45 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |